Litak is used in the treatment of certain types of blood cancer. It works by inhibiting the growth and multiplication
of cancer cells within the body. The medication contains an active ingredient that helps reduce the activity of
abnormal cells.
It is administered under strict medical supervision in specialized healthcare centers. Litak may help improve the
body’s response to treatment in some patients and requires continuous monitoring during therapy to avoid potential
complications and regularly assess the patient’s condition.
Composition of Litak
Litak contains the following active ingredient:
Dosage Forms of Litak
Litak is available as injectable vials containing 10 mg of cladribine. Each pack contains 5 vials intended for
injection use.
Indications for Litak
Main uses include:
Treatment of certain types of leukemia
Management of hairy cell leukemia
Reducing the growth of cancer cells
Supporting treatment plans for hematological malignancies
Limiting the spread of abnormal cells
Dosage of Litak
The appropriate dose is determined according to the patient’s weight, medical condition, and response to therapy. The
medication must be administered under specialized medical supervision to ensure safe use.
Litak is given by injection according to the prescribed treatment protocol. The dose may be adjusted based on
laboratory tests and periodic medical evaluations. Strict adherence to the treatment schedule is important to achieve
the best therapeutic results.
Side Effects of Litak
Common side effects may include:
Contraindications of Litak
Litak should not be used in cases of hypersensitivity to cladribine or any of the product’s components. It is
contraindicated in patients with severe immune suppression unless under close medical supervision.
It should also be avoided during severe infections or pregnancy unless deemed absolutely necessary by the physician.
Patients with liver or kidney disorders require careful monitoring before and during treatment.
Alternatives to Litak
Available alternatives include:
Use During Pregnancy and Breastfeeding
Litak should be used with extreme caution during pregnancy and breastfeeding. It is contraindicated during pregnancy
except in life-threatening situations under strict medical supervision.
A physician should be consulted before use during breastfeeding due to the possibility of the active ingredient
passing into breast milk. Effective contraception is recommended throughout the treatment period, and breastfeeding
should be discontinued while using the medication to ensure the child’s safety.
Storage Conditions
Store at the medically recommended temperature
Keep away from direct light
Store in the original packaging
Keep out of reach of children
Do not use after the expiration date